These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
256 related items for PubMed ID: 16393249
21. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma. Kanellou P, Zaravinos A, Zioga M, Spandidos DA. Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278 [Abstract] [Full Text] [Related]
22. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis. Kanellou P, Zaravinos A, Zioga M, Stratigos A, Baritaki S, Soufla G, Zoras O, Spandidos DA. Cancer Lett; 2008 Jun 08; 264(1):145-61. PubMed ID: 18331779 [Abstract] [Full Text] [Related]
23. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis. Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN. J Med Assoc Thai; 1999 May 08; 82(5):466-76. PubMed ID: 10443096 [Abstract] [Full Text] [Related]
24. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma. Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS. Arch Otolaryngol Head Neck Surg; 2006 Apr 08; 132(4):409-15. PubMed ID: 16618910 [Abstract] [Full Text] [Related]
25. Familial head and neck cancer: molecular analysis of a new clinical entity. Yu KK, Zanation AM, Moss JR, Yarbrough WG. Laryngoscope; 2002 Sep 08; 112(9):1587-93. PubMed ID: 12352668 [Abstract] [Full Text] [Related]
26. Reliable detection of p53 aberrations in squamous cell carcinomas of the head and neck requires transcript analysis of the entire coding region. Hauser U, Balz V, Carey TE, Grénman R, Van Lierop A, Scheckenbach K, Bier H. Head Neck; 2002 Sep 08; 24(9):868-73. PubMed ID: 12211051 [Abstract] [Full Text] [Related]
27. Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients. van Zeeburg HJ, Snijders PJ, Pals G, Hermsen MA, Rooimans MA, Bagby G, Soulier J, Gluckman E, Wennerberg J, Leemans CR, Joenje H, Brakenhoff RH. Cancer Res; 2005 Feb 15; 65(4):1271-6. PubMed ID: 15735012 [Abstract] [Full Text] [Related]
28. Genetic instabilities of chromosome 9, 17 and accumulation of p53 overexpression during multistage tumorigesis in head and neck cancer. Charuruks N, Shin DM, Voravud N, Ro JY, Hong WK, Hittelman WN. J Med Assoc Thai; 1996 Dec 15; 79 Suppl 1():S104-12. PubMed ID: 9071074 [Abstract] [Full Text] [Related]
29. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Tabor MP, Brakenhoff RH, van Houten VM, Kummer JA, Snel MH, Snijders PJ, Snow GB, Leemans CR, Braakhuis BJ. Clin Cancer Res; 2001 Jun 15; 7(6):1523-32. PubMed ID: 11410486 [Abstract] [Full Text] [Related]
30. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Edström S, Cvetkovska E, Westin T, Young C. Laryngoscope; 2001 Jan 15; 111(1):124-30. PubMed ID: 11192880 [Abstract] [Full Text] [Related]
31. P53 mutation correlates with cisplatin sensitivity in head and neck squamous cell carcinoma lines. Bradford CR, Zhu S, Ogawa H, Ogawa T, Ubell M, Narayan A, Johnson G, Wolf GT, Fisher SG, Carey TE. Head Neck; 2003 Aug 15; 25(8):654-61. PubMed ID: 12884349 [Abstract] [Full Text] [Related]
32. Genetic aberration in primary hepatocellular carcinoma: correlation between p53 gene mutation and loss-of-heterozygosity on chromosome 16q21-q23 and 9p21-p23. Wang G, Huang CH, Zhao Y, Cai L, Wang Y, Xiu SJ, Jiang ZW, Yang S, Zhao T, Huang W, Gu JR. Cell Res; 2000 Dec 15; 10(4):311-23. PubMed ID: 11191353 [Abstract] [Full Text] [Related]
33. Genetic discordance between primary tumours and metastases of head and neck cancer detected by microsatellite analysis. Götte K, Riedel F, Schäfer C, Coy JF, Hörmann K. Oncol Rep; 2002 Dec 15; 9(4):829-34. PubMed ID: 12066217 [Abstract] [Full Text] [Related]
34. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17. Wolf C, Flechtenmacher C, Dietz A, Weidauer H, Abel U, Maier H, Bosch FX. Laryngoscope; 2004 Apr 15; 114(4):698-704. PubMed ID: 15064627 [Abstract] [Full Text] [Related]
35. Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K. Cancer Res; 2000 Jun 15; 60(12):3143-6. PubMed ID: 10866301 [Abstract] [Full Text] [Related]
36. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing. Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D. Cancer Res; 2004 Sep 01; 64(17):5982-7. PubMed ID: 15342377 [Abstract] [Full Text] [Related]
37. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers. Fiedler W, Hoppe C, Schimmel B, Koscielny S, Dahse R, Bereczki Z, Claussen U, Ernst G, von Eggeling F. Int J Mol Med; 2002 Apr 01; 9(4):417-23. PubMed ID: 11891539 [Abstract] [Full Text] [Related]
38. Frequent mutations in TP53 and CDKN2A found by next-generation sequencing of head and neck cancer cell lines. Nichols AC, Yoo J, Palma DA, Fung K, Franklin JH, Koropatnick J, Mymryk JS, Batada NN, Barrett JW. Arch Otolaryngol Head Neck Surg; 2012 Aug 01; 138(8):732-9. PubMed ID: 22911296 [Abstract] [Full Text] [Related]
39. Abrogation of the p16-retinoblastoma-cyclin D1 pathway in head and neck squamous cell carcinomas. Park HW, Song SY, Lee TJ, Jeong D, Lee TY. Oncol Rep; 2007 Jul 01; 18(1):267-72. PubMed ID: 17549378 [Abstract] [Full Text] [Related]
40. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM, Taylor PR. Clin Cancer Res; 2001 Apr 01; 7(4):883-91. PubMed ID: 11309337 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]